Ester Baiget, CEO of biosolutions company, Novonesis discusses HY earnings, and explains how the company is navigating tariff-related uncertainty.
Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG
Get this delivered to your inbox, and more info about our products and services.
Vas Narasimhan, CEO of pharmaceuticals company, Novartis, discusses the company's latest $12 billion acquisition of Avidity…
Karsten Munk Knudsen, CFO of Novo Nordisk, discusses the prospect of tariffs on pharmaceuticals and the importance of the U.S.…
Novo Nordisk CEO Mike Doustdar discusses the pharma giant's Q4 reporting, uptake of obesity drugs and how he plans to navigate…
Mike Doustdar, new CEO of Ozempic maker, Novo Nordisk discusses his strategy for the future of the company.
Renault, Elekta, Tietoevry and a number of others have recently reset expectations with investors.
Nvidia CEO Jensen Huang told CNBC's Jim Cramer on Tuesday that there's "no drama involved" between the company and OpenAI.…
